DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers

We began analyzing https://www.nature.com/articles/2401236, but it redirected us to https://www.nature.com/articles/2401236. The analysis below is for the second page.

Title[redir]:
Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects | Leukemia
Description:
While it is known that mice with genetic immune defects are useful for establishing durable engraftment of human tumor xenografts, the relative role of components of host innate and adoptive immunity in engraftment has not been determined. We directly compared the ability of four strains of genetically immunodeficient mice (NOD/SCID, SCID, Nude and Rag-1-deficient) to successfully engraft and support the human cell lines Daudi, Raji, Namalwa and Molt-4 as subcutaneous tumors. We additionally examined the effect of further immunosuppression of the mice by whole body irradiation at a dose of 600 cGy for Nude and Rag-1 and 300 cGy for SCID mice and by administration of anti-natural killer (asialo-GM1) antibody on tumor growth. Mice with each of the defects supported xenografts to varying degrees. We found differences in growth characteristics in the cell lines tested, with Namalwa consistently producing the largest tumors. With all cell lines studied, optimal growth was achieved using NOD/SCID mice. Overall, tumor growth was somewhat enhanced by pretreatment with radiation with little additional benefit from the addition of anti-asialo-GM1 antibody. The importance of multiple components of the innate and adoptive immune system in xenotransplantation were best demonstrated when results in untreated NOD/SCID mice were compared to SCID, nude and RAG-1-deficient mice. The NOD/SCID mouse with or without additional immunosuppression provides the optimal model for the study of the biology and treatment of human leukemias and lymphomas.

Matching Content Categories {📚}

Science
Social Networks
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

nature, article, mice, access, content, cookies, privacy, leukemia, human, tumor, nodscid, cell, growth, data, defects, immune, mouse, open, cancer, reports, scientific, advertising, information, subscribe, biotechnical, methods, section, bts, december, xenotransplantation, multiple, hudson, xenografts, scid, nude, lines, immunosuppression, additional, institution, buy, editing, permissions, research, optional, media, personal, parties, varying, policy, journals,

Topics {✒️}

nature portfolio permissions reprints privacy policy nature advertising social media personal data untreated nod/scid mice springerlink instant access data protection permissions anti-asialo-gm1 antibody anti-natural killer genetic immune defects defects supported xenografts multiple immunologic defects tumor immune microenvironment human tumor xenografts privacy bts cell lines tested cell lines studied adoptive immune system nod/scid mouse humanized mouse models nod/scid mice severe combined immunodeficiency explore content subscription content promotes cell growth genetically immunodeficient mice european economic area human lymphoid malignancies issue learn institutional subscriptions read laboratory medicine/pathology bone subcutaneous transplantation poor prognosis marker accepting optional cookies journals search log article hudson manage preferences establishing durable engraftment namalwa consistently producing content subscribe leukemia access rag-1-deficient mice nod/scid article purchase

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects
         description:While it is known that mice with genetic immune defects are useful for establishing durable engraftment of human tumor xenografts, the relative role of components of host innate and adoptive immunity in engraftment has not been determined. We directly compared the ability of four strains of genetically immunodeficient mice (NOD/SCID, SCID, Nude and Rag-1-deficient) to successfully engraft and support the human cell lines Daudi, Raji, Namalwa and Molt-4 as subcutaneous tumors. We additionally examined the effect of further immunosuppression of the mice by whole body irradiation at a dose of 600âcGy for Nude and Rag-1 and 300âcGy for SCID mice and by administration of anti-natural killer (asialo-GM1) antibody on tumor growth. Mice with each of the defects supported xenografts to varying degrees. We found differences in growth characteristics in the cell lines tested, with Namalwa consistently producing the largest tumors. With all cell lines studied, optimal growth was achieved using NOD/SCID mice. Overall, tumor growth was somewhat enhanced by pretreatment with radiation with little additional benefit from the addition of anti-asialo-GM1 antibody. The importance of multiple components of the innate and adoptive immune system in xenotransplantation were best demonstrated when results in untreated NOD/SCID mice were compared to SCID, nude and RAG-1-deficient mice. The NOD/SCID mouse with or without additional immunosuppression provides the optimal model for the study of the biology and treatment of human leukemias and lymphomas.
         datePublished:1998-12-08T00:00:00Z
         dateModified:1998-12-08T00:00:00Z
         pageStart:2029
         pageEnd:2033
         sameAs:https://doi.org/10.1038/sj.leu.2401236
         keywords:
            NOD/SCID mice
            xenografts
            leukemia/lymphoma
            immunosuppression
            Medicine/Public Health
            general
            Internal Medicine
            Intensive / Critical Care Medicine
            Cancer Research
            Oncology
            Hematology
         image:
         isPartOf:
            name:Leukemia
            issn:
               1476-5551
               0887-6924
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:WA Hudson
               affiliation:
                     name:Cancer Center, University of Minnesota
                     address:
                        name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Q Li
               affiliation:
                     name:Cancer Center, University of Minnesota
                     address:
                        name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C Le
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Division of Biostatistics, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:JH Kersey
               affiliation:
                     name:Cancer Center, University of Minnesota
                     address:
                        name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects
      description:While it is known that mice with genetic immune defects are useful for establishing durable engraftment of human tumor xenografts, the relative role of components of host innate and adoptive immunity in engraftment has not been determined. We directly compared the ability of four strains of genetically immunodeficient mice (NOD/SCID, SCID, Nude and Rag-1-deficient) to successfully engraft and support the human cell lines Daudi, Raji, Namalwa and Molt-4 as subcutaneous tumors. We additionally examined the effect of further immunosuppression of the mice by whole body irradiation at a dose of 600âcGy for Nude and Rag-1 and 300âcGy for SCID mice and by administration of anti-natural killer (asialo-GM1) antibody on tumor growth. Mice with each of the defects supported xenografts to varying degrees. We found differences in growth characteristics in the cell lines tested, with Namalwa consistently producing the largest tumors. With all cell lines studied, optimal growth was achieved using NOD/SCID mice. Overall, tumor growth was somewhat enhanced by pretreatment with radiation with little additional benefit from the addition of anti-asialo-GM1 antibody. The importance of multiple components of the innate and adoptive immune system in xenotransplantation were best demonstrated when results in untreated NOD/SCID mice were compared to SCID, nude and RAG-1-deficient mice. The NOD/SCID mouse with or without additional immunosuppression provides the optimal model for the study of the biology and treatment of human leukemias and lymphomas.
      datePublished:1998-12-08T00:00:00Z
      dateModified:1998-12-08T00:00:00Z
      pageStart:2029
      pageEnd:2033
      sameAs:https://doi.org/10.1038/sj.leu.2401236
      keywords:
         NOD/SCID mice
         xenografts
         leukemia/lymphoma
         immunosuppression
         Medicine/Public Health
         general
         Internal Medicine
         Intensive / Critical Care Medicine
         Cancer Research
         Oncology
         Hematology
      image:
      isPartOf:
         name:Leukemia
         issn:
            1476-5551
            0887-6924
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:WA Hudson
            affiliation:
                  name:Cancer Center, University of Minnesota
                  address:
                     name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Q Li
            affiliation:
                  name:Cancer Center, University of Minnesota
                  address:
                     name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C Le
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Division of Biostatistics, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:JH Kersey
            affiliation:
                  name:Cancer Center, University of Minnesota
                  address:
                     name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Leukemia
      issn:
         1476-5551
         0887-6924
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Center, University of Minnesota
      address:
         name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:Cancer Center, University of Minnesota
      address:
         name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Division of Biostatistics, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:Cancer Center, University of Minnesota
      address:
         name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:WA Hudson
      affiliation:
            name:Cancer Center, University of Minnesota
            address:
               name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Q Li
      affiliation:
            name:Cancer Center, University of Minnesota
            address:
               name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:C Le
      affiliation:
            name:University of Minnesota
            address:
               name:Division of Biostatistics, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:JH Kersey
      affiliation:
            name:Cancer Center, University of Minnesota
            address:
               name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
      name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
      name:Division of Biostatistics, University of Minnesota, Minneapolis, USA
      name:Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(1)

https://twitter.com/LeukemiaJnl

External Links {🔗}(106)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

4.06s.